Reducing inflammation in people living with HIV
Part of Immune system & allergy, Infections clinical trials.
This trial tests if a drug can lower inflammation in people with HIV who are on effective treatment. It may help reduce the risk of heart disease and other problems related to chronic inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 or older, or have had HIV for 25 years or more
- Your HIV viral load is undetectable (below 50 copies/mL) in the last 6 months
- You have at least one cardiovascular risk factor, like high blood pressure, diabetes, smoking, high cholesterol, or a family history of heart disease
- You have had detectable sgp120 levels in your blood in the past year (a marker of inflammation)
- You are not taking medications that interfere with the study drug, and you do not have severe liver or heart problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if colchicine, a medicine for inflammation, can reduce swelling in the heart arteries of people with HIV. It may help lower the risk of heart problems in those already on a statin or similar medication.
This study tests whether a combination approach, including a drug called nicotinamide (a form of vitamin B3) and other strategies, can reduce the hidden HIV reservoir enough to allow a temporary pause in antiretroviral therapy without the virus rebounding. It is for people who have well-controlled HIV and strong immune systems.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This study tests whether a daily supplement called genistein, derived from soy, can help reduce the risk of heart problems in people living with HIV. It aims to see if genistein can improve blood vessel function and lower inflammation, potentially protecting your heart.
This program provides access to an investigational HIV medication called fostemsavir for people who have run out of standard options due to drug resistance or intolerance. It aims to help control the virus when other combinations fail.
This Phase 2 study looks at whether lowering inflammation can help improve depression symptoms in adults living with HIV. You may be able to join if your HIV is well controlled and you are currently experiencing major depression (or a certain type of bipolar depression).
Hear when a new Cardiovascular Risk Factor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.